Brain diseases — psychiatric and neurologic, affecting children and adults — account for about 35 % of Europe's total disease burden with expenses exceeding EUR 386 billion. Pharmacological intervention is ineffective as the blood–brain barrier (BBB) limits access to the brain.
Further information: cordis.europa.eu